Latest News

June 20, 2002
A second type of Botulinum toxin - type B (brand name Myobloc®) —may be as effective as type A (brand name Botox®) for the treatment of facial wrinkles, according to UCSF researchers. The study, among the first to analyze the effectiveness of type B in prospective clinical trial, appears in the current issue of Otolaryngology - Head and Neck Surgery. 
June 19, 2002
As the 118 students in the Class of 2002 prepare to graduate June 22 from the UCSF School of Pharmacy - the nation’s top-ranked pharmacy school - they face a surging job market and a growing array of professional options. They enter their profession as the nation faces a potentially dangerous shortage of pharmacists, according to a federal study and state experts. The main reasons:
June 13, 2002
Neuroscientists at UCSF’s Ernest Gallo Clinic and Research Center (EGCRC) have discovered that a molecule in neurons boosts the brain’s response to alcohol, triggering in minutes chemical changes that maintain an urge to drink alcohol. Blocking the molecule’s action might prevent excessive drinking, they conclude.
June 10, 2002
Costs for osteoporosis in California topped $2.4 billion in 1998, with hip fracture accounting for 64 percent of the burden, according to researchers in the UCSF School of Nursing Institute for Health & Aging. The study, the first to analyze cost of osteoporosis in California, appears in the June, 2002 issue of Osteoporosis International.
June 04, 2002
Washington Post Senior Editor and 1993 Pulitzer Prize Winner for Distinguished Literary Criticism Michael D. Dirda, PhD, will be the keynote speaker for the 2002 UCSF School of Dentistry Commencement. 
June 03, 2002
A new journal series, “Quality Grand Rounds,” will harness the power of individual case presentations to educate health care providers about medical errors. The first article in a series of eight appears in the June 4, 2002 issue of the Annals of Internal Medicine and at
June 02, 2002
Nearly three million cataract surgeries are performed every year in the United States. The majority of patients must wear prescription glasses after the procedure to see properly.  But a new technology may eliminate this problem. Based on technology developed by researchers from UCSF and Cal Tech, Calhoun Vision, Inc. is developing a photosensitive silicone intraocular lens.  This lens can be adjusted - non-invasively, weeks after surgery—with a low-power source of light to eliminate refractive errors post implantation.
May 29, 2002
Scientists have discovered that a type of childhood leukemia starts with a genetic mutation in the womb and can take 12 years or more to progress into the life-threatening cancer - the longest “latency period” yet identified between the initiating genetic event and diagnosis of leukemia. Discovery of such a long time lag between the initial event and full development of leukemia suggests that even some adult leukemia may start in the womb, the researchers conclude.
May 29, 2002
The tobacco industry’s own documents show that most youth smoking prevention programs it has supported are designed to promote industry political and marketing aims rather than to reduce smoking, according to researchers who analyzed nearly 500 industry documents.
May 29, 2002
The tobacco industry engaged in aggressive intelligence gathering to combat tobacco control groups—including the use of intermediaries to obtain materials under false pretenses, sending public relations spies to public health organization meetings, and covertly taping strategy sessions, according to an analysis of internal tobacco industry documents by Ruth E. Malone, assistant professor of nursing and health policy in the UCSF School of Nursing. The analysis appears in the June, 2002 issue of the American Journal of Public Health.